To your point @goedy there is a single part-government-funded DNA test 'Cologuard' in the US, however, it's a POO test costing around $500. Insurance companies like it because it's cheaper than a colonoscopy.
The various DNA PLASMA (blood) tests in development to date are not good at detecting advanced adenomas (pre-cancerous polyps), they only achieve around 20% sensitivity. The whole point of population screening is early detection.
Rhythm's Colostat on the other hand achieves 87.5% sensitivity for Stage 1, so we can assume at least 60% for advanced adenomas. It offers cheap ELISA-based (readily available), and accurate testing.
Note - Cologuard only achieves 42% sensitivity for advanced adenomas.
Rhythm is now on a mission to manufacture a new automated version of its test kit and then collect the required data regarding the reliability of the device itself. I believe the data will easily meet the IVDR requirements.
- Forums
- ASX - By Stock
- Future Announcements
To your point @goedy there is a single part-government-funded...
-
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
6.0¢ |
Change
-0.002(3.23%) |
Mkt cap ! $14.91M |
Open | High | Low | Value | Volume |
6.0¢ | 6.0¢ | 5.9¢ | $9.212K | 153.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17675 | 6.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 76753 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17675 | 0.060 |
3 | 66200 | 0.059 |
1 | 17241 | 0.058 |
1 | 54545 | 0.055 |
2 | 79995 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 76753 | 3 |
0.071 | 150525 | 1 |
0.072 | 2245 | 1 |
0.075 | 9200 | 1 |
0.084 | 43251 | 2 |
Last trade - 15.49pm 01/07/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online